Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study

OBJECTIVE: This study was done for collection of real world data of Aripiprazole Once Monthly (AOM) in patients with schizophrenia. METHODS: The observation was up to 12 months from the first use of AOM in patients with antipsychotic polypharmacy (APpoly)/other long acting injectable antipsychotics...

Descripción completa

Detalles Bibliográficos
Autores principales: Pae, Chi-Un, Han, Changsu, Bahk, Won-Myong, Lee, Soo-Jung, Patkar, Ashwin A., Masand, Prakash S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006969/
https://www.ncbi.nlm.nih.gov/pubmed/31958916
http://dx.doi.org/10.9758/cpn.2020.18.1.153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006969/
https://www.ncbi.nlm.nih.gov/pubmed/31958916
http://dx.doi.org/10.9758/cpn.2020.18.1.153

Ejemplares similares